Global Neurology Devices Market - 2025 -2033
Neurology Devices Market Size and Growth
The global neurology devices market reached US$ 23.95 billion in 2023, with a rise to US$ 25.30 billion in 2024, and is expected to reach US$ 43.28 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033. The market growth is driven by increasing prevalence of neurological disorders, technological advancements in diagnostic and therapeutic devices, and rising healthcare infrastructure investments worldwide.
Neurology Devices Market Key Market Trends & Insights
Driver: Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is expected to drive the demand for neurology devices. For instance, according to Yale Medicine, approximately 795,000 Americans experience a stroke each year, with about 87% classified as ischemic strokes. Stroke incidence is notably higher among adults aged 65 and older, as the risk increases significantly with age, making it a leading neurological concern in the aging U.S. population.
Conditions such as Alzheimer's disease, Parkinson’s disease, epilepsy, multiple sclerosis, and stroke are becoming increasingly common, particularly with aging populations across developed and developing regions. This surge in neurological conditions fuels demand for advanced diagnostic, monitoring, and therapeutic devices that can improve patient outcomes and quality of life. Thus, the above factors are driving the neurology devices market.
Restraint: High Cost of Therapy
The high cost of neurology devices poses a significant challenge to the market’s growth, especially in low- and middle-income regions. Advanced diagnostic and therapeutic equipment, such as neuroimaging systems, implantable neuromodulation devices, and wearable monitors, often require substantial investment in both acquisition and maintenance. These elevated costs limit accessibility for many healthcare providers and patients, restricting widespread adoption. As a result, despite the growing demand for neurology devices, the high price barrier may slow market penetration and hinder equitable healthcare delivery, particularly in resource-limited settings.
Neurology Devices Market Segment Analysis
The global neurology devices market is segmented based on product type, disease type, end-user, and region.
Product Type - The cerebrospinal fluid (CSF) management devices segment is estimated to have 32.8% of the neurology devices market share.
Cerebrospinal fluid (CSF) management devices are poised to dominate the neurology devices market, driven by significant technological advancements and strategic collaborations in 2023 and 2024. In August 2024, Aesculap, Inc. and Christoph Miethke GmbH & Co. KG received FDA Breakthrough Device Designation for their M.scio System, a non-invasive, telemetric system providing continuous intracranial pressure (ICP) monitoring through an implantable sensor. This innovation offers real-time CSF assessment, enhancing hydrocephalus management and positioning CSF management devices at the forefront of neurology device advancements.
Furthermore, in January 2023, Biogen and Alcyone Therapeutics entered a partnership to develop ThecaFlex DRx, an implantable device for subcutaneous administration of antisense oligonucleotides (ASOs) into the CSF. This system represents a significant leap in intrathecal medication delivery, expanding the therapeutic applications of CSF management devices beyond traditional uses. These developments underscore the growing importance and versatility of CSF management devices in the neurology sector, highlighting their potential to lead the market in the coming years.
Neurology Devices Market Geographical Share
The North America neurology devices market was valued at 39.7% market share in 2024
North America is poised to maintain its leadership in the global neurology devices market, driven by a confluence of demographic, technological, and healthcare infrastructure factors. In 2023, the region accounted for approximately 39.7% of the global market share, with the United States being the largest contributor.
A significant driver is the rising prevalence of neurological disorders. For instance, Alzheimer's disease affects over 6 million Americans aged 65 and older, a number projected to nearly double by 2050. This aging population is increasingly susceptible to conditions such as Parkinson’s disease, epilepsy, and stroke, thereby escalating the demand for advanced diagnostic and therapeutic devices.
Technological innovation further propels market growth. The U.S. Food and Drug Administration (FDA) has approved several cutting-edge devices, including the NeuroPace RNS System for epilepsy management. Companies like Medtronic, Boston Scientific, and Abbott Laboratories are at the forefront, investing heavily in research and development to introduce minimally invasive and wearable neurology devices. For instance, in February 2025, Johnson & Johnson MedTech, a rising leader in neurovascular care, announced the launch of the CEREGLIDE 92 Catheter System, a next-generation .092” catheter designed to support complex neurovascular interventions. The system features the innovative INNERGLIDE 9 delivery aid and is indicated for facilitating the insertion and navigation of interventional devices within the neurovascular system, offering enhanced performance and precision in endovascular procedures.
Neurology Devices Market Major Players
The major players in the neurology devices market include Stryker, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic, Penumbra Inc., Abbott, NIHON KOHDEN CORPORATION, B. Braun SE, MicroPort Scientific Corporation, among others.
Key Developments:
The global neurology devices market reached US$ 23.95 billion in 2023, with a rise to US$ 25.30 billion in 2024, and is expected to reach US$ 43.28 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033. The market growth is driven by increasing prevalence of neurological disorders, technological advancements in diagnostic and therapeutic devices, and rising healthcare infrastructure investments worldwide.
Neurology Devices Market Key Market Trends & Insights
- North America accounted for approximately 39.7% of the global neurology devices market in 2023 and is expected to retain a significant market share throughout the forecast period.
- Asia Pacific is anticipated to be the fastest-growing region, supported by expanding healthcare facilities, growing awareness of neurological conditions, and increasing demand for advanced medical devices.
- By product type, the cerebrospinal fluid management devices segment is expected to hold a major portion of the market, holding 32.8%.
- Ongoing innovations in neuroimaging, neuromodulation, and neurodiagnostic devices are expected to further fuel market expansion.
- 2024 Market Size: USD 25.30 Billion
- 2033 Projected Market Size: USD 43.28 Billion
- CAGR (2025–2033): 6.2%
- North America: Largest market in 2023
- Asia Pacific: Fastest-growing market.
Driver: Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders is expected to drive the demand for neurology devices. For instance, according to Yale Medicine, approximately 795,000 Americans experience a stroke each year, with about 87% classified as ischemic strokes. Stroke incidence is notably higher among adults aged 65 and older, as the risk increases significantly with age, making it a leading neurological concern in the aging U.S. population.
Conditions such as Alzheimer's disease, Parkinson’s disease, epilepsy, multiple sclerosis, and stroke are becoming increasingly common, particularly with aging populations across developed and developing regions. This surge in neurological conditions fuels demand for advanced diagnostic, monitoring, and therapeutic devices that can improve patient outcomes and quality of life. Thus, the above factors are driving the neurology devices market.
Restraint: High Cost of Therapy
The high cost of neurology devices poses a significant challenge to the market’s growth, especially in low- and middle-income regions. Advanced diagnostic and therapeutic equipment, such as neuroimaging systems, implantable neuromodulation devices, and wearable monitors, often require substantial investment in both acquisition and maintenance. These elevated costs limit accessibility for many healthcare providers and patients, restricting widespread adoption. As a result, despite the growing demand for neurology devices, the high price barrier may slow market penetration and hinder equitable healthcare delivery, particularly in resource-limited settings.
Neurology Devices Market Segment Analysis
The global neurology devices market is segmented based on product type, disease type, end-user, and region.
Product Type - The cerebrospinal fluid (CSF) management devices segment is estimated to have 32.8% of the neurology devices market share.
Cerebrospinal fluid (CSF) management devices are poised to dominate the neurology devices market, driven by significant technological advancements and strategic collaborations in 2023 and 2024. In August 2024, Aesculap, Inc. and Christoph Miethke GmbH & Co. KG received FDA Breakthrough Device Designation for their M.scio System, a non-invasive, telemetric system providing continuous intracranial pressure (ICP) monitoring through an implantable sensor. This innovation offers real-time CSF assessment, enhancing hydrocephalus management and positioning CSF management devices at the forefront of neurology device advancements.
Furthermore, in January 2023, Biogen and Alcyone Therapeutics entered a partnership to develop ThecaFlex DRx, an implantable device for subcutaneous administration of antisense oligonucleotides (ASOs) into the CSF. This system represents a significant leap in intrathecal medication delivery, expanding the therapeutic applications of CSF management devices beyond traditional uses. These developments underscore the growing importance and versatility of CSF management devices in the neurology sector, highlighting their potential to lead the market in the coming years.
Neurology Devices Market Geographical Share
The North America neurology devices market was valued at 39.7% market share in 2024
North America is poised to maintain its leadership in the global neurology devices market, driven by a confluence of demographic, technological, and healthcare infrastructure factors. In 2023, the region accounted for approximately 39.7% of the global market share, with the United States being the largest contributor.
A significant driver is the rising prevalence of neurological disorders. For instance, Alzheimer's disease affects over 6 million Americans aged 65 and older, a number projected to nearly double by 2050. This aging population is increasingly susceptible to conditions such as Parkinson’s disease, epilepsy, and stroke, thereby escalating the demand for advanced diagnostic and therapeutic devices.
Technological innovation further propels market growth. The U.S. Food and Drug Administration (FDA) has approved several cutting-edge devices, including the NeuroPace RNS System for epilepsy management. Companies like Medtronic, Boston Scientific, and Abbott Laboratories are at the forefront, investing heavily in research and development to introduce minimally invasive and wearable neurology devices. For instance, in February 2025, Johnson & Johnson MedTech, a rising leader in neurovascular care, announced the launch of the CEREGLIDE 92 Catheter System, a next-generation .092” catheter designed to support complex neurovascular interventions. The system features the innovative INNERGLIDE 9 delivery aid and is indicated for facilitating the insertion and navigation of interventional devices within the neurovascular system, offering enhanced performance and precision in endovascular procedures.
Neurology Devices Market Major Players
The major players in the neurology devices market include Stryker, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic, Penumbra Inc., Abbott, NIHON KOHDEN CORPORATION, B. Braun SE, MicroPort Scientific Corporation, among others.
Key Developments:
- In February 2025, Penumbra introduced the Access25 delivery microcatheter, a single-lumen medical device engineered to assist physicians in navigating the neurovasculature for precise delivery of Penumbra’s advanced 0.020-inch coil platform.
- In February 2024, Royal Philips, a global leader in health technology, unveiled significant upgrades to its Image Guided Therapy System. This advanced interventional platform is designed to enhance clinical productivity, enable faster decision-making, increase patient throughput, and improve treatment outcomes.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Disease Type
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Neurological Disorders
3.1.1.2. Technological Advancements
3.1.2. Restraints
3.1.2.1. High Cost of Neurology Devices
3.1.2.2. Regulatory Challenges
3.1.3. Opportunity
3.1.3.1. Integration of AI and Machine Learning
3.1.3.2. Collaborations and Partnerships
3.1.4. Impact Analysis
4. GLOBAL NEUROLOGY DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL NEUROLOGY DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Cerebrospinal Fluid Management Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Neurostimulation Devices
5.4. Interventional Neurology
5.5. Neurosurgery Devices
5.6. Others
6. GLOBAL NEUROLOGY DEVICES MARKET: BY DISEASE TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
6.1.2. Market Attractiveness Index, By Disease Type
6.2. Fistulas and Arteriovenous Malformations*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Ischemic Strokes
6.4. Cerebral Aneurysms
6.5. Carotid Artery Stenosis
6.6. Others
7. GLOBAL NEUROLOGY DEVICES MARKET: BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals & Clinics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Centers
7.4. Others
8. GLOBAL NEUROLOGY DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Boston Scientific Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Stryker
10.3. Integra LifeSciences Holdings Corporation
10.4. Johnson and Johnson
10.5. Medtronic
10.6. Penumbra Inc.
10.7. Abbott
10.8. NIHON KOHDEN CORPORATION
10.9. B. Braun SE
10.10. MicroPort Scientific Corporation (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Disease Type
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Prevalence of Neurological Disorders
3.1.1.2. Technological Advancements
3.1.2. Restraints
3.1.2.1. High Cost of Neurology Devices
3.1.2.2. Regulatory Challenges
3.1.3. Opportunity
3.1.3.1. Integration of AI and Machine Learning
3.1.3.2. Collaborations and Partnerships
3.1.4. Impact Analysis
4. GLOBAL NEUROLOGY DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL NEUROLOGY DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Cerebrospinal Fluid Management Devices*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Neurostimulation Devices
5.4. Interventional Neurology
5.5. Neurosurgery Devices
5.6. Others
6. GLOBAL NEUROLOGY DEVICES MARKET: BY DISEASE TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
6.1.2. Market Attractiveness Index, By Disease Type
6.2. Fistulas and Arteriovenous Malformations*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Ischemic Strokes
6.4. Cerebral Aneurysms
6.5. Carotid Artery Stenosis
6.6. Others
7. GLOBAL NEUROLOGY DEVICES MARKET: BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals & Clinics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Specialty Centers
7.4. Others
8. GLOBAL NEUROLOGY DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Boston Scientific Corporation*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Stryker
10.3. Integra LifeSciences Holdings Corporation
10.4. Johnson and Johnson
10.5. Medtronic
10.6. Penumbra Inc.
10.7. Abbott
10.8. NIHON KOHDEN CORPORATION
10.9. B. Braun SE
10.10. MicroPort Scientific Corporation (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global Neurology Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Neurology Devices Market Value, By Disease Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Neurology Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Neurology Devices Market Value, By Disease Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 9 Global Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Neurology Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 15 North America Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 23 Europe Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 South America Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 27 South America Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Boston Scientific Corporation: Overview
Table 34 Boston Scientific Corporation: Product Portfolio
Table 35 Boston Scientific Corporation: Key Developments
Table 36 Stryker: Overview
Table 37 Stryker: Product Portfolio
Table 38 Stryker: Key Developments
Table 39 Integra LifeSciences Holdings Corporation: Overview
Table 40 Integra LifeSciences Holdings Corporation: Product Portfolio
Table 41 Integra LifeSciences Holdings Corporation: Key Developments
Table 42 Johnson and Johnson: Overview
Table 43 Johnson and Johnson: Product Portfolio
Table 44 Johnson and Johnson: Key Developments
Table 45 Medtronic: Overview
Table 46 Medtronic: Product Portfolio
Table 47 Medtronic: Key Developments
Table 48 Penumbra Inc.: Overview
Table 49 Penumbra Inc.: Product Portfolio
Table 50 Penumbra Inc.: Key Developments
Table 51 Abbott: Overview
Table 52 Abbott: Product Portfolio
Table 53 Abbott: Key Developments
Table 54 NIHON KOHDEN CORPORATION: Overview
Table 55 NIHON KOHDEN CORPORATION: Product Portfolio
Table 56 NIHON KOHDEN CORPORATION: Key Developments
Table 57 B. Braun SE: Overview
Table 58 B. Braun SE: Product Portfolio
Table 59 B. Braun SE: Key Developments
Table 60 MicroPort Scientific Corporation: Overview
Table 61 MicroPort Scientific Corporation: Product Portfolio
Table 62 MicroPort Scientific Corporation: Key Developments
Table 1 Global Neurology Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Neurology Devices Market Value, By Disease Type, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Neurology Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Neurology Devices Market Value, By Disease Type, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 9 Global Neurology Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Neurology Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Neurology Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 15 North America Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 23 Europe Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 South America Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 27 South America Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Neurology Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Neurology Devices Market Value, By Disease Type, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Neurology Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Neurology Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Boston Scientific Corporation: Overview
Table 34 Boston Scientific Corporation: Product Portfolio
Table 35 Boston Scientific Corporation: Key Developments
Table 36 Stryker: Overview
Table 37 Stryker: Product Portfolio
Table 38 Stryker: Key Developments
Table 39 Integra LifeSciences Holdings Corporation: Overview
Table 40 Integra LifeSciences Holdings Corporation: Product Portfolio
Table 41 Integra LifeSciences Holdings Corporation: Key Developments
Table 42 Johnson and Johnson: Overview
Table 43 Johnson and Johnson: Product Portfolio
Table 44 Johnson and Johnson: Key Developments
Table 45 Medtronic: Overview
Table 46 Medtronic: Product Portfolio
Table 47 Medtronic: Key Developments
Table 48 Penumbra Inc.: Overview
Table 49 Penumbra Inc.: Product Portfolio
Table 50 Penumbra Inc.: Key Developments
Table 51 Abbott: Overview
Table 52 Abbott: Product Portfolio
Table 53 Abbott: Key Developments
Table 54 NIHON KOHDEN CORPORATION: Overview
Table 55 NIHON KOHDEN CORPORATION: Product Portfolio
Table 56 NIHON KOHDEN CORPORATION: Key Developments
Table 57 B. Braun SE: Overview
Table 58 B. Braun SE: Product Portfolio
Table 59 B. Braun SE: Key Developments
Table 60 MicroPort Scientific Corporation: Overview
Table 61 MicroPort Scientific Corporation: Product Portfolio
Table 62 MicroPort Scientific Corporation: Key Developments
LIST OF FIGURES
Figure 1 Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 4 Global Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Neurology Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Neurology Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Cerebrospinal Fluid Management Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Neurostimulation Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Interventional Neurology Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Neurosurgery Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Others Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Neurology Devices Market Y-o-Y Growth, By Disease Type, 2023-2033 (%)
Figure 13 Fistulas and Arteriovenous Malformations Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Ischemic Strokes Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Cerebral Aneurysms Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Carotid Artery Stenosis Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Others Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Neurology Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 19 Hospitals & Clinics End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Specialty Centers End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Others End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Neurology Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 23 North America Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 24 North America Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 25 North America Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 26 North America Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 27 North America Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 28 Asia-Pacific Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 29 Asia-Pacific Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 Asia-Pacific Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 31 Asia-Pacific Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 32 Asia-Pacific Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 33 Europe Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 34 Europe Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Europe Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 36 Europe Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Europe Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 38 South America Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 39 South America Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 South America Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 41 South America Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 42 South America Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 43 Middle East and Africa Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 44 Middle East and Africa Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 45 Middle East and Africa Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 46 Middle East and Africa Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 47 Boston Scientific Corporation: Financials
Figure 48 Stryker: Financials
Figure 49 Integra LifeSciences Holdings Corporation: Financials
Figure 50 Johnson and Johnson: Financials
Figure 51 Medtronic: Financials
Figure 52 Penumbra Inc.: Financials
Figure 53 Abbott: Financials
Figure 54 NIHON KOHDEN CORPORATION: Financials
Figure 55 B. Braun SE: Financials
Figure 56 MicroPort Scientific Corporation: Financials
Figure 1 Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 4 Global Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Neurology Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Neurology Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Cerebrospinal Fluid Management Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Neurostimulation Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Interventional Neurology Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Neurosurgery Devices Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 Others Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Global Neurology Devices Market Y-o-Y Growth, By Disease Type, 2023-2033 (%)
Figure 13 Fistulas and Arteriovenous Malformations Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Ischemic Strokes Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Cerebral Aneurysms Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Carotid Artery Stenosis Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 17 Others Disease Type in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Neurology Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 19 Hospitals & Clinics End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Specialty Centers End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Others End-User in Global Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Neurology Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 23 North America Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 24 North America Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 25 North America Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 26 North America Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 27 North America Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 28 Asia-Pacific Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 29 Asia-Pacific Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 Asia-Pacific Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 31 Asia-Pacific Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 32 Asia-Pacific Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 33 Europe Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 34 Europe Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Europe Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 36 Europe Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Europe Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 38 South America Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 39 South America Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 South America Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 41 South America Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 42 South America Neurology Devices Market Share, By Country, 2024 & 2033 (%)
Figure 43 Middle East and Africa Neurology Devices Market Value, 2022-2033 (US$ Billion)
Figure 44 Middle East and Africa Neurology Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 45 Middle East and Africa Neurology Devices Market Share, By Disease Type, 2024 & 2033 (%)
Figure 46 Middle East and Africa Neurology Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 47 Boston Scientific Corporation: Financials
Figure 48 Stryker: Financials
Figure 49 Integra LifeSciences Holdings Corporation: Financials
Figure 50 Johnson and Johnson: Financials
Figure 51 Medtronic: Financials
Figure 52 Penumbra Inc.: Financials
Figure 53 Abbott: Financials
Figure 54 NIHON KOHDEN CORPORATION: Financials
Figure 55 B. Braun SE: Financials
Figure 56 MicroPort Scientific Corporation: Financials
